Ibrutinib approved to treat WM in EUJuly 11, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
IDH1 inhibitor gets orphan designation for AMLJune 12, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML